CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $773 | +2660.7% | 28,405 | +2145.5% | 0.00% | – |
| Q2 2023 | $28 | -47.2% | 1,265 | -52.4% | 0.00% | – |
| Q4 2022 | $53 | -99.9% | 2,657 | +13.7% | 0.00% | – |
| Q3 2022 | $59,000 | -1.7% | 2,336 | -7.7% | 0.00% | – |
| Q2 2022 | $60,000 | +2900.0% | 2,530 | +2286.8% | 0.00% | – |
| Q1 2022 | $2,000 | -97.0% | 106 | -96.9% | 0.00% | – |
| Q4 2021 | $66,000 | -94.8% | 3,369 | -94.8% | 0.00% | -100.0% |
| Q3 2021 | $1,274,000 | +1669.4% | 64,787 | +1865.0% | 0.00% | – |
| Q2 2021 | $72,000 | -7.7% | 3,297 | 0.0% | 0.00% | – |
| Q1 2021 | $78,000 | -9.3% | 3,297 | 0.0% | 0.00% | – |
| Q4 2020 | $86,000 | +22.9% | 3,297 | -18.6% | 0.00% | – |
| Q3 2020 | $70,000 | +133.3% | 4,050 | +121.9% | 0.00% | – |
| Q2 2020 | $30,000 | -42.3% | 1,825 | -58.7% | 0.00% | – |
| Q1 2020 | $52,000 | +1633.3% | 4,417 | +1673.9% | 0.00% | – |
| Q4 2019 | $3,000 | -99.0% | 249 | -98.6% | 0.00% | -100.0% |
| Q4 2017 | $314,000 | – | 17,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |